Company / Total Assets
Biohaven Ltd. Total Assets History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$615.1M
FY2024
5-year range
$142.1M / $661.8M
FY2021-FY2024
Trend
+19.9%
vs FY2023
Sector context
#122 of 214
Health Care
What the data says
At $615M, Biohaven Ltd.'s total assets ranks #122 of 214 in the Health Care sector. Declined from $662M to $615M over the past 2 years.
Based on SEC 10-K filings.
$615M in FY2024 with a 3-year CAGR of +63.0%.
Declined from $662M to $615M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +63.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#122 of 214 in Health CareTop 57% of 214This company $615.1M Sector average $7.5B
▼
-91.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +63.0%, indicating consistent growth.
- In FY2024, total assets increased 19.9% year-over-year.
- Ranks #122 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $615.1M | +19.9% |
| FY2023 | $513.2M | -22.5% |
| FY2022 | $661.8M | +365.8% |
| FY2021 | $142.1M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026